Phoenix, AZ, ( Uptick Newswire – December 12, 2017) – Uptick Newswire is the sole producer of the Uptick Network “Stock Day” Podcast and after airing back in January 2016 CEO and host Everett Jolly has interviewed hundreds of CEO’s within the micro-cap publicly traded sector of the market bringing important updates to the investor community. The Company that joined Everett Jolly on Stock Day today is in a broad spectrum of the cannabis industry and keeps the Stock Day listeners updated regularly on where the Company is at within the industry.
Starting off the interview Mr. Jolly introduces the returning guest and gives a great introduction to this unique Company, “The Company seeks to be an innovative technology and solutions Company that converts the cannabis plant into medicines, therapies and treatments for a variety of ailments. It also plans to produce consistent and measurable medical grade cannabis, cannabis concentrates and cannabinoid therapies.”
Stock Day welcomes back John Poss, CEO of GB Sciences Inc. (OTCQB:GBLX) (the “Company”) as he gives the low down on GB Sciences four cannabis tiers and explains what great importance each of these tiers hold within the Company and the cannabis industry. Continuing his explanation, Mr. Poss elaborates on the Company patents, dosing, compounds, along with much more and further explains the individual importance of the companies within GB Sciences. Mr. Jolly springs the question on Mr. Poss regarding when an investor invests into GB Sciences and Mr. Poss sheds light on that unique investment. He elaborates on that question letting investors know that they aren’t just investing into one Company but they are investing in numerous pieces of the puzzle that makes up GB Sciences as a whole.
In a closings statement CEO John Poss states, “There’s one principal that drives us and helps people understand medical versus regulation simplistically we believe that every consumer of cannabis deserves to have the best cannabis, medical grade cannabis, whether they are using it for recreational purposes or specific medical purposes, everyone deserves the best and that’s what we are providing to those segments of the market.”
To listen to the full interview please click here or the following link: https://upticknewswire.com/featured-interview-ceo-john-poss-of-gb-sciences-inc-otcqb-gblx-2
About Uptick Newswire and the “Stock Day Podcast”
Uptick Newswire is a private company reaching out to the masses keeping investors and shareholders up to date on company news and bringing transparency to the undervalued, undersold, micro-cap stocks of the market and is the sole producer of the Uptick Network “Stock Day” Podcast. The Uptick Network “Stock Day” Podcast is an extension of Uptick Newswire and has recently launched the Video Interview Studio located in Phoenix Arizona with its new host Kathryn Donnelly.
Investors Hangout is a proud sponsor of Stock Day and Uptick Newswire encourages listeners to visit GB Sciences message board on: https://investorshangout.com/GrowBlox-Sciences-Inc-GBLX-67373/
About GB Sciences, Inc.
GB Sciences, Inc. (GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. The Company’s goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. To learn more about GB Sciences, Inc., go to: http://gbsciences.com.
This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as “expects”, “intends”, “plans”, “may”, “could”, “should”, “anticipates”, “likely”, “believes” and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company’s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company’s control. It is possible that the Company’s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company’s business and financial and other results, are contained in the Company’s filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.
Uptick Newswire LLC
Everett Jolly, CEO/Founder
10000 N. 31st Avenue C307
Phoenix, AZ 85051
Source: Uptick Newswire